Pfizer Says Lipitor Buyers Can't Bring Antitrust Challenge
Pfizer Inc. sought Friday to end a class action concerning its purportedly anti-competitive settlement resolving patent litigation over Ranbaxy Inc.'s generic challenge to Pfizer's cholesterol drug Lipitor, telling a New Jersey...To view the full article, register now.
Already a subscriber? Click here to view full article